Disclosures for "Incidence and Patient Characteristics of Newly Diagnosed Hereditary Transthyretin Amyloidosis-Polyneuropathy in the Medicare Fee-for-Service Population: Variation by Race/Ethnicity, Income, and Geography"
-
The institution of Dr. Nativi-Nicolau has received research support from Alnylam.
-
The institution of Dr. Bazell has received research support from AstraZeneca.
-
The institution of Ms. Alston has received research support from AstraZeneca.
-
Dr. Papas has received personal compensation for serving as an employee of AstraZeneca. Dr. Papas has stock in AstraZeneca.
-
John Venditto has received personal compensation for serving as an employee of AstraZeneca . John Venditto has stock in AstraZeneca .